D. Petzinna

685 total citations
14 papers, 498 citations indexed

About

D. Petzinna is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, D. Petzinna has authored 14 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 5 papers in Cardiology and Cardiovascular Medicine and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in D. Petzinna's work include Diabetes Treatment and Management (4 papers), Cardiovascular Function and Risk Factors (3 papers) and Microbial Metabolism and Applications (2 papers). D. Petzinna is often cited by papers focused on Diabetes Treatment and Management (4 papers), Cardiovascular Function and Risk Factors (3 papers) and Microbial Metabolism and Applications (2 papers). D. Petzinna collaborates with scholars based in Germany, Austria and United States. D. Petzinna's co-authors include Thomas Evers, Paul Cullen, H. Schulte, Gerd Assmann, Uwe Zeymer, P Segal, Cheston M. Berlin, G. Schernthaner, Rolf Angerbauer and Delf Schmidt and has published in prestigious journals such as Diabetes Care, European Heart Journal and Atherosclerosis.

In The Last Decade

D. Petzinna

14 papers receiving 462 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Petzinna Germany 11 220 150 115 99 61 14 498
Yoshiya HATA Japan 15 215 1.0× 311 2.1× 106 0.9× 144 1.5× 21 0.3× 35 692
Francisco Javier del Cañizo-Gómez Spain 6 327 1.5× 104 0.7× 34 0.3× 150 1.5× 49 0.8× 13 543
EJ Schaefer United States 10 327 1.5× 249 1.7× 133 1.2× 119 1.2× 20 0.3× 10 739
R. Mella Italy 5 250 1.1× 110 0.7× 21 0.2× 132 1.3× 49 0.8× 7 444
Jörgen Mölgaard Sweden 8 81 0.4× 228 1.5× 67 0.6× 57 0.6× 40 0.7× 14 459
J. Stephen Canada 4 143 0.7× 195 1.3× 38 0.3× 139 1.4× 43 0.7× 8 572
Kazuaki Enya Japan 9 169 0.8× 94 0.6× 105 0.9× 134 1.4× 19 0.3× 17 465
Sandra Bacon United States 11 193 0.9× 368 2.5× 78 0.7× 247 2.5× 38 0.6× 16 629
S. Irie Japan 12 147 0.7× 233 1.6× 30 0.3× 88 0.9× 74 1.2× 17 819
Nebil Attia Tunisia 12 140 0.6× 142 0.9× 41 0.4× 81 0.8× 13 0.2× 18 360

Countries citing papers authored by D. Petzinna

Since Specialization
Citations

This map shows the geographic impact of D. Petzinna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Petzinna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Petzinna more than expected).

Fields of papers citing papers by D. Petzinna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Petzinna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Petzinna. The network helps show where D. Petzinna may publish in the future.

Co-authorship network of co-authors of D. Petzinna

This figure shows the co-authorship network connecting the top 25 collaborators of D. Petzinna. A scholar is included among the top collaborators of D. Petzinna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Petzinna. D. Petzinna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Segal, P, et al.. (2005). Long-Term Efficacy and Tolerability of Acarbose Treatment in Patients with Type 2 Diabetes Mellitus. Clinical Drug Investigation. 25(9). 589–595. 12 indexed citations
2.
Assmann, Gerd, Paul Cullen, Thomas Evers, D. Petzinna, & H. Schulte. (2005). Importance of arterial pulse pressure as a predictor of coronary heart disease risk in PROCAM. European Heart Journal. 26(20). 2120–2126. 108 indexed citations
3.
Neuser, D., et al.. (2005). Safety and Tolerability of Acarbose in the Treatment of Type 1 and Type 2 Diabetes Mellitus. Clinical Drug Investigation. 25(9). 579–587. 35 indexed citations
4.
Balletshofer, Bernd, Kilian Rittig, M. Enderle, et al.. (2005). Intense Cholesterol Lowering Therapy with a HMG-CoA Reductase Inhibitor does not Improve Nitric Oxide Dependent Endothelial Function in Type-2-Diabetes. Experimental and Clinical Endocrinology & Diabetes. 113(6). 324–330. 23 indexed citations
5.
Zeymer, Uwe, et al.. (2004). Effect of acarbose treatment on the risk of silent myocardial infarctions in patients with impaired glucose tolerance: results of the randomised STOP-NIDDM trial electrocardiography substudy. European Journal of Cardiovascular Prevention & Rehabilitation. 11(5). 412–415. 46 indexed citations
6.
Zeymer, Uwe, et al.. (2004). Effect of acarbose treatment on the risk of silent myocardial infarctions in patients with impaired glucose tolerance: results of the randomised STOP-NIDDM trial electrocardiography substudy. European Journal of Cardiovascular Prevention & Rehabilitation. 11(5). 412–415. 26 indexed citations
7.
Bachmann, W. E., D. Petzinna, S. Raptis, Thomas C. Wascher, & Torsten Westermeier. (2003). Long-Term Improvement of Metabolic Control by Acarbose in Type 2 Diabetes Patients Poorly Controlled with Maximum Sulfonylurea Therapy. Clinical Drug Investigation. 23(10). 679–686. 14 indexed citations
8.
Hauner, Hans, D. Petzinna, Bernd Sommerauer, & Hermann Toplak. (2001). Effect of acarbose on weight maintenance after dietary weight loss in obese subjects *. Diabetes Obesity and Metabolism. 3(6). 423–427. 19 indexed citations
9.
Bischoff, Hilmar, Rolf Angerbauer, D. Petzinna, et al.. (1998). Preclinical review of cerivastatin sodium—a step forward in HMG-CoA reductase inhibition. Atherosclerosis. 139. 7–13. 17 indexed citations
10.
Bischoff, Hilmar, Rolf Angerbauer, Erwin Bischoff, et al.. (1997). Cerivastatin: pharmacology of a novel synthetic and highly active HMG-CoA reductase inhibitor. Atherosclerosis. 135(1). 119–130. 94 indexed citations
11.
12.
Bojar, Hans, L. Weißbach, D. Petzinna, Kitti Maár, & W. Staib. (1985). Steroid Receptor Status of Human Testicular Tumors. Urologia Internationalis. 40(3). 160–163. 3 indexed citations
13.
Bojar, Hans, et al.. (1984). Steroid receptor pattern of human colorectal neoplasms.. PubMed. 4(3). 129–32. 5 indexed citations
14.
Bojar, Hans, et al.. (1984). Steroid receptor status of focal-nodular hyperplasia of the human liver. Journal of Molecular Medicine. 62(10). 446–450. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshiya HATA Breakdown of academic impact, for papers by Francisco Javier del Cañizo-Gómez Breakdown of academic impact, for papers by EJ Schaefer Breakdown of academic impact, for papers by R. Mella Breakdown of academic impact, for papers by Jörgen Mölgaard Breakdown of academic impact, for papers by J. Stephen Breakdown of academic impact, for papers by Kazuaki Enya Breakdown of academic impact, for papers by Sandra Bacon Breakdown of academic impact, for papers by S. Irie Breakdown of academic impact, for papers by Nebil Attia
Rankless by CCL
2026